Literature DB >> 3927656

Estimation of glomerular filtration rate in children using 99m-technetium DTPA. A comparison with 51-chromium EDTA clearance.

H K Yap, F X Sundram, W C Yip, J S Tay, E S Ang, H J Toh, V T Joseph, A H Saw.   

Abstract

The usefulness of radionuclide imaging studies with 99m-technetium diethylenetriaminepentaacetic acid (Tc-DTPA) for quantitating the glomerular filtration rate (GFR) in children was studied. This was compared to the conventional methods for measuring GFR using 51-chromium-EDTA clearance (Cr-EDTA), creatinine clearance and a height/plasma creatinine formula. In the 22 children studied, the correlation coefficient between renal uptake of DTPA and Cr-EDTA was 0.90 (p less than 0.001). In contrast, there was a poorer correlation between Cr-EDTA and creatinine clearance (r = 0.69) or the derived GFR using height/creatinine formula (r = 0.83). The regression line between Tc-DTPA uptake and Cr-EDTA clearance was used to derive a formula for calculating the predicted GFR. This was tested in 10 additional children, and the correlation between the predicted GFR and measured GFR (using Cr-EDTA clearance studies) was 0.92 (p less than 0.001). Quantitative estimation of the GFR during renal imaging studies is a feasible and convenient method of assessing renal function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927656     DOI: 10.1111/j.1651-2227.1985.tb11033.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  2 in total

1.  Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children.

Authors:  F Chiarelli; A Verrotti; G Morgese
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

2.  Comparison of glomerular filtration rate measured by plasma sample technique, Cockroft Gault method and Gates' method in voluntary kidney donors and renal transplant recipients.

Authors:  Julie Hephzibah; Nylla Shanthly; Regi Oommen
Journal:  Indian J Nucl Med       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.